Bal Pharma reports consolidated net loss of Rs 3.15 crore in the March 2016 quarter

Sales rise 7.87% to Rs 53.88 crore

Net loss of Bal Pharma reported to Rs 3.15 crore in the quarter ended March 2016 as against net profit of Rs 0.34 crore during the previous quarter ended March 2015. Sales rose 7.87% to Rs 53.88 crore in the quarter ended March 2016 as against Rs 49.95 crore during the previous quarter ended March 2015.

For the full year,net profit declined 71.52% to Rs 1.41 crore in the year ended March 2016 as against Rs 4.95 crore during the previous year ended March 2015. Sales rose 6.76% to Rs 194.82 crore in the year ended March 2016 as against Rs 182.48 crore during the previous year ended March 2015.

ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales53.8849.95 8 194.82182.48 7 OPM %3.409.53 -7.639.38 - PBDT-0.023.98 PL 9.6611.76 -18 PBT-2.270.40 PL 2.654.74 -44 NP-3.150.34 PL 1.414.95 -72

Powered by Capital Market - Live News